Companies: 10,795·Total market cap: $144.5T
Alvotech

Alvotech

ALVONASDAQHealthcare● Active
$4.09
+$0.55(+15.40%)
Market Cap$1.3B
P/E Ratio—
52W High$11.12
52W Low$2.94
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Alvotech (ALVO) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001898416 · ALVO · NASDAQ · as of Jun 8, 2026

Filing snapshot

284
Total Filings
6-K
Latest Form
2026-06-04
Most Recent
2022
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001898416 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-03-31
Fiscal Year End
Mar 31, 2026
Accession No.
0001898416-26-000004
Primary Document
alvo-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001898416 · Accession 0001898416-26-000004

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-06-04
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-04
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-11
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-04
View
20-FAnnual Report (Foreign Issuer)
20-F
2026-03-31
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-19
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-03-12
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-02-27
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-02-05
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-02-02
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-01-29
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-01-07
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-01-07
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-01-06
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-01-02
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-12-23
View
Showing 1–15 of 284 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001898416  |  Exchange: NASDAQ · Healthcare

Alvotech (NASDAQ: ALVO) has submitted 284 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Healthcare sector company with CIK 0001898416, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Alvotech's most comprehensive regulatory disclosure. The most recent Alvotech 10-K was filed on 2026-03-31 for fiscal year ending 2026. Historical ALVO 10-K annual reports are available from 2021 through 2026.

Investors researching Alvotech SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
SEM SEC Filings →PGNY SEC Filings →UFPT SEC Filings →PAHC SEC Filings →HROW SEC Filings →BHVN SEC Filings →COLL SEC Filings →EVO SEC Filings →
→ ALVO Financials→ ALVO Earnings→ ALVO Insider Trades

Frequently Asked Questions

ALVO SEC Filings · 8 questions

Alvotech (ALVO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 284 filings and access original documents at no cost. Alvotech's CIK is 0001898416.

ALVO SEC filingsAlvotech SEC documentsfind ALVO 10-K